Third Rock Ventures III, L.P. Insider Trading $NRIX Nurix Therapeutics, Inc.
Get free email notifications about insider trading for Third Rock Ventures III, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Third Rock Ventures III, L.P.. Third Rock Ventures III, L.P. is 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Voyager Therapeutics, Inc. ($VYGR) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Fulcrum Therapeutics, Inc. ($FULC) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Neon Therapeutics, Inc. ($NTGN) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Relay Therapeutics, Inc. ($RLAY).
Third Rock Ventures III, L.P. in Nurix Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures III, L.P.: 10% Owner
Holdings: 3,422,549 shares
Latest Transaction: May 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Third Rock Ventures III, L.P. in Nurix Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EDIT, FULC, GBT, MYOK, NTGN, NRIX, PLRX, RLAY, RVMD, VYGR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Sell | J | 0.00 | 1,085,784 | 0 | 3,422,549 | 4.5 M to 3.4 M (-24.08 %) |
| May 10 2021 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Sell | J | 0.00 | 1,085,784 | 0 | 3,422,549 | 4.5 M to 3.4 M (-24.08 %) |
| Feb 08 2021 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Sell | J | 0.00 | 914,216 | 0 | 4,508,333 | 5.4 M to 4.5 M (-16.86 %) |
| Jul 29 2020 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 39,216 | 0 | 0 | |
| Jul 29 2020 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,508,333 | 0 | 0 | |
| Jul 29 2020 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 875,000 | 0 | 0 | |
| Jul 29 2020 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 39,216 | 0 | 5,422,549 | 5.4 M to 5.4 M (+0.73 %) |
| Jul 29 2020 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 4,508,333 | 0 | 5,383,333 | 875 K to 5.4 M (+515.24 %) |
| Jul 29 2020 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 875,000 | 0 | 875,000 | 0 to 875 K |
Page: 1